Tower Research Capital (TRC)’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Buy |
|
|||||
|
2025
Q1 | $13.1K | Buy |
|
|||||
|
2024
Q4 | $12.5K | Buy |
|
|||||
|
2024
Q3 | $11.4K | Sell |
|
|||||
|
2024
Q2 | $36K | Buy |
|
|||||
|
2024
Q1 | $8.95K | Sell |
|
|||||
|
2023
Q4 | $64.1K | Buy |
|
|||||
|
2023
Q3 | $42.9K | Buy |
|
|||||
|
2023
Q2 | $11.7K | Sell |
|
|||||
|
2023
Q1 | $25K | Buy |
|
|||||
|
2022
Q4 | $10K | Sell |
|
|||||
|
2022
Q3 | $63K | Buy |
|
|||||
|
2022
Q2 | $51K | Sell |
|
|||||
|
2022
Q1 | $44K | Sell |
|
|||||
|
2021
Q4 | $68K | Buy |
|
|||||
|
2021
Q3 | $37K | Buy |
|